Quince Therapeutics, Inc. (QNCX) Shareholder/Analyst Call Prepared Remarks Transcript
Quince Therapeutics Inc QNCX
$0.95
โฒ +4.66%
(+$0.04)
Open
$0.90
Prev Close
$0.90
Day Range
$0.89 โ $1.01
52W Range
$0.79 โ $45.50
Market Cap
$15.41M
Beta
1.38
EPS (TTM)
$-9.11
๐ Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-09 |
| Shares Out. | 16,300,000 |
| Website | quincetx.com/ โ |
| Phone | 14159105717 |
Quince Therapeutics Inc is a publicly traded company under the ticker symbol QNCX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
8 analysts (2026-06-01)
